Abstract：Objective: To investigate the changes of serum high-sensitivity C-reactive protein (hs CRP) and ESR in patients with active pulmonary tuberculosis and their relationship with prognosis. Methods: The clinical data of 79 patients with active pulmonary tuberculosis treated in our hospital from May 2018 to may 2019 were retrospectively analyzed. According to the sputum smear and sputum culture results after 4 months of anti tuberculosis treatment, they were divided into negative group (62 cases) and positive group (17 cases). The levels of hs-CRP and ESR in the two groups were detected, and the relationship between the levels of hs-CRP and ESR and the prognosis of patients with active pulmonary tuberculosis was analyzed by multivariate logistic regression. Results: There was no significant difference between the two groups (P>0.05). Before treatment, there was no significant difference in hs-CRP and ESR between the two groups (Pall>0.05). After treatment, the levels of hs-CRP and ESR in the two groups were lower than those before treatment, the difference was statistically significant (P<0.05), and the levels of hs-CRP and ESR in the negative group were lower than those in the positive group, the difference was statistically significant (P<0.05). Multivariate logistic regression analysis showed that serum hs-CRP and ESR levels were independent risk factors affecting the prognosis of patients with active tuberculosis (P<0.01). Conclusions:The changes of serum high-sensitivity C-reactive protein and ESR have a certain relationship with the prognosis of patients with active pulmonary tuberculosis. Dynamic monitoring of the changes of serum high-sensitivity C-reactive protein and ESR has a guiding significance for evaluating the prognosis of patients with active pulmonary tuberculosis.
冯雄, 郑友彬, 郑友彬. 活动性肺结核患者血清超敏C反应蛋白血沉水平变化与预后关系分析[J]. 河北医学, 2020, 26(8): 1260-1263.
FENG Xiong, ZHENG Youbin. Analysis on the Relationship between the Changes of Serum Hs-CRP ESR and Prognosis in Patients with Active Tuberculosis. HeBei Med, 2020, 26(8): 1260-1263.
[1] Eun-Jeong Won, Jung-Ho Choi, Young-Nan Cho, et al.Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease[J].Journal of Infection, 2016, 74(3):281~293. [2] Sara C Auld, Scott H Lee, Eleanor S Click, et al.Interferon gamma release assay result is associated with disease site and death in active tuberculosis[J].Ann Am Thorac Soc, 2016, 13(12):2151~2158. [3] James Brown, Kristina Clark, Colette Smith, et al.Variation in C-reactive protein response according to host and mycobacterial characteristics in active tuberculosis[J].Bmc Infectious Diseases, 2016, 16(1):265. [4] Gao L, Li X, Liu J, et al.Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China:follow-up results of a population-based, multicentre, prospective cohort study[J].2017, 17(10):1053~1061. [5] 曾令城, 柳巍.2011-2013年西安市肺结核流行病学特征分析[J].中国社会医学杂志, 2016, 33(4):380~383. [6] 陈杰, 韩红洋, 吴志嵩, 等.并发2型糖尿病的肺结核患者外周血白细胞介素6和C反应蛋白水平的研究[J].中国防痨杂志, 2019, 41(2):236~238. [7] 李春达, 陶学芳.慢性阻塞性肺疾病伴肺结核患者炎症因子变化及其与结核病变的关系[J].国际流行病学传染病学杂志, 2019, 46(2):122~125. [8] 汪海涛, 凌敏.联合检测降钙素原、血沉、C-反应蛋白在活动性肺结核中的临床意义[J].临床肺科杂志, 2014, 19(8):1466~1469. [9] 任甜甜, 刘翔.结核感染T细胞斑点试验检测对老年活动性肺结核的诊断价值[J].河北医学, 2017, 23(4):623~626. [10] 张俊瑶, 海占兵, 王敏, 等.血清超敏C反应蛋白水平与突发性聋患者预后关系的研究[J].中国听力语言康复科学杂志, 2019, 17(4):270~274. [11] 陈颜强, 赵青, 李薇, 等.结核性脑膜炎伴发肺结核的临床研究及检验方法的对比[J].河北医科大学学报, 2019, 40(5):504~507. [12] 李静, 李恭鹏.血清C-反应蛋白及血沉对急性胰腺炎的诊断价值[J].中国卫生检验杂志, 2019, 29(7):892~896.
2020, Vol. 26 
冀公网安备13080202000786号